David L. Kemmerly files SEC Form 4 disclosures for AMEDISYS INC. They have made 18 open-market trades across 1 company since 2018, most recently 2022-03-29.
CIK 0001673554
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMED | 16,779 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2022-04-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMED | SELL | 2022-03-29 | 2022-04-04 | $177.32 | $883K | -10.2% | -26.8% | -32.6% |
| AMED | SELL | 2021-04-27 | 2021-04-29 | $290.12 | $1.4M | -8.6% | -9.3% | -10.9% |
| AMED | SELL | 2021-04-09 | 2021-04-13 | $280.00 | $140K | +2.1% | -10.1% | -3.6% |
| AMED | SELL | 2021-04-01 | 2021-04-02 | $270.00 | $136K | +2.4% | -3.0% | -3.4% |
| AMED | SELL | 2020-06-09 | 2020-06-11 | $176.74 | $558K | +15.1% | +15.6% | +33.8% |
| AMED | SELL | 2020-05-05 | 2020-05-07 | $175.32 | $8.2M | +9.0% | +2.0% | +33.8% |
| AMED | SELL | 2020-02-24 | 2020-02-26 | $187.29 | $456K | -10.6% | -10.9% | +1.0% |
| AMED | SELL | 2019-06-10 | 2019-06-12 | $117.77 | $957K | +3.1% | +4.1% | +12.9% |
| AMED | SELL | 2019-06-10 | 2019-06-12 | $117.77 | $957K | +3.1% | +4.1% | +12.9% |
| AMED | SELL | 2019-06-06 | 2019-06-06 | $113.40 | $501K | +6.3% | +8.1% | +15.8% |
| AMED | SELL | 2019-05-30 | 2019-06-03 | $113.48 | $567K | +6.2% | +7.4% | +15.8% |
| AMED | SELL | 2019-05-20 | 2019-05-21 | $109.96 | $550K | -0.4% | +8.6% | +19.3% |
| AMED | SELL | 2019-05-10 | 2019-05-14 | $115.18 | $1.1M | -0.4% | +7.3% | +18.6% |
| AMED | SELL | 2019-05-07 | 2019-05-09 | $118.20 | $591K | -3.9% | +1.1% | +14.6% |
| AMED | SELL | 2018-12-12 | 2018-12-14 | $133.82 | $836K | -7.8% | -4.7% | +1.0% |
| AMED | SELL | 2018-11-14 | 2018-11-16 | $116.88 | $730K | +7.8% | -6.3% | +10.1% |
| AMED | SELL | 2018-11-07 | 2018-11-09 | $119.29 | $1.1M | -0.8% | +7.0% | +11.0% |
| AMED | SELL | 2018-06-07 | 2018-06-11 | $79.02 | $474K | +7.5% | +13.9% | +51.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.